- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News 79 results
In the News · Quelle: JUVE
November 22, 2022
Novartis setzt sich mit King & Spalding in Vorlageverfahren vor dem EuGH zum Umverpacken von Arzneimitteln durch
Cases & Deals
November 17, 2022
Parallelimport von Arzneimitteln - King & Spalding vertritt Novartis vor dem EuGH
Recognition
November 4, 2022
JUVE Handbook 2022/23 Recognizes Multiple King & Spalding Practices, Individuals
In the News · Quelle: JUVE
Oktober 13, 2022
Immobilienspezialist Moritz Heidbuechel wechselt zu King & Spalding
In the News · Quelle: JUVE
September 20, 2022
King & Spalding verstärkt Steuerteam mit erfahrenem Counsel Martin Wolff
Press Release
September 1, 2022
King & Spalding verstärkt sich mit fünfköpfigem Frankfurter Corporate-Team unter Leitung von Partner Dr. Peter Memminger
In the News
In the News · Quelle: JUVE
August 22, 2022
K&S berät Circular Resources SARL bei dem Finanzierungspaket für den Ankauf von DSD - Duales System Holding GmbH & Co. KG (DSD)
Cases & Deals
August 10, 2022
King & Spalding Advises on Financing for Circular Resources' Recycling Acquisitions
In the News · Quelle: Immobilien Zeitung, The Global Legal Post and Legal Era
Juni 30, 2022
Axel Schilder wird Office Managing Partner bei King & Spalding
Recognition
Juni 23, 2022
Best Lawyers Recognizes International King & Spalding Lawyers in its 2023 Guides